AbbVie Inc. against Lonza Group AG — live side-by-side technical comparison.
Prices as of 2026-09-23T20:03:50+00:00 UTC · updates daily
ABBV leads 4 of the 5 windows we measure — over 1 month ABBV is +0.2% and LONN.SW -4.4%; over year to date ABBV is +16.0% and LONN.SW +4.5%.
| ABBV | LONN.SW | |
|---|---|---|
| Price | $265.08 | $561.80 |
| 1 day | -0.1%lead | -0.2% |
| 5 days | +1.0% | +4.3%lead |
| 1 month | +0.2%lead | -4.4% |
| 6 months | +29.4%lead | +20.2% |
| Year to date | +16.0%lead | +4.5% |
| 52-week position | 95% of range | 75% of range |
| 52-week range | $190.75–$269.39 | $454.60–$597.80 |
| vs 50-day average | above $256.43 | below $564.23 |
| vs 200-day average | above $230.16 | above $530.05 |
| RSI (14) | 55 | 38 |
| Next earnings | 2026-10-29 | 2026-01-28 |
ABBV trades at $265.08, above its 50-day average of $256.43, and above the 200-day at $230.16. It sits at 95% of its 52-week range ($190.75–$269.39); 14-day RSI is 55, in neutral territory; an average session moves it about 2.1%. For levels, the first level overhead is $265.97 (0.3% away) and the first support below is $262.28 (1.1% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
LONN.SW trades at $561.80, below its 50-day average of $564.23, and above the 200-day at $530.05. It sits at 75% of its 52-week range ($454.60–$597.80); 14-day RSI is 38, in neutral territory; an average session moves it about 1.9%. For levels, the first level overhead is $564.23 (0.4% away) and the first support below is $554.70 (1.3% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
ABBV is the more volatile of the two — an average session moves it 2.1% against 1.9% for LONN.SW, so an identical position size carries roughly 1.1× the daily risk.
The comparison turns on those levels: ABBV clearing $265.97 or losing $262.28; LONN.SW clearing $564.23 or losing $554.70. Until one of them gives way, the relative reading above stands.